Leading SMEs of India 2021

32 Experts' View Leading SMEs of India 2021 How would you describe the journey of your company since its inception? Well, talking about the Company's journey The company commenced its operation in 2006 with the aim of dyes intermediates. With passage of time it drastically showed good success and progressed well. With the growing results of the company. In 2011, We had a brain-child to Diversify Bhagwati Organics into Pharmaceutical Sector Under this we substantially decided to explore the field of basic pharma intermediates. Our core team members worked hard in Diversifying our product portfolio. It is all together efforts to convert the idea into reality. Our next vision was to take one more step forward. In 2016 We Constructed a new facility to cater regulatory and international market with compliance to WHO GMP standards. Facility was set to cater the global growing Pharmaceutical industry. Bhagwati Organics Private Limited Bonny S. Patel Executive Director What are some of the key milestones of the company in recent years? In recent years ¾ BOPL commissioned its state of the art GMP facility for the manufacturing of API’s and Intermediates at Ahmedabad, Gujarat. ¾ We achieved the production volume of 200MT/M from 45MT/M since commencing of the new facility. ¾ We achieved a significant growth of 1200% in sales. ¾ Built up a strong team of 60 persons having average 15 years of experience in the Pharmaceutical Industry. ¾ We expanded our business network globally across 19 countries. In recent times we developed new key products which boosted our company’s performance. Some of them are 1-Acetyl- 4-(4-hydroxyphenyl)piperazine 3-Amino-1H-pyrazole-4-carboxamide hemisulfate 1-(3-Chlorophenyl)-4-(3-chloropropyl) piperazine 1,2,4-Triazolo[4,3-a] pyridin-3(2H)-one What are your growth strategies for the next 3 to 5 years? Moving to the growth strategy we are aiming to focus on 2 major strategies. ConsideringMarket Development through regulatory submissions as the first one, we are focusing on increasing sales of the existing products to unexplored market. We are working to submit Potential products DMF, Dossiers submission to various recognised regulatory authorities to cater the global requirements. Another we are focusing on product development under this strategy we are planning to launch new products to cater the needs of existing as well as new customers. Company has already acquired a land to built up a newmanufacturing unit as per global regulatory requirements, the unit will be commissioned by late 2023. Dun & Bradstreet